CACNA1B and non-small cell lung carcinoma: In the current study, we determined both mRNA and protein expression of CACNA1B (Cav2.2) in NSCLC tissue samples by quantitative reverse transcription PCR (qRT-PCR) and tissue microarray immunohistochemistry analysis (TMA-IHC), respectively, and correlated to patients' clinical characteristics and overall survival.